Editorials

Emergency treatment of anaphylaxis

BMJ 2008; 336 doi: http://dx.doi.org/10.1136/bmj.39547.452153.80 (Published 22 May 2008) Cite this as: BMJ 2008;336:1141
  1. F Estelle R Simons, professor
  1. 1Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada R3A 1R9
  1. lmcniven{at}hsc.mb.ca

    Revised UK guidelines are a concise evidence based resource

    The Resuscitation Council of the United Kingdom recently updated its guidelines on the emergency treatment of anaphylactic reactions.1 The guidelines stress the importance of an early call for help from a resuscitation team or an ambulance. They introduce the ABCDE approach (airway, breathing, circulation, disability (level of consciousness), and exposure (of the skin)). They emphasise that prompt intramuscular injection of adrenaline (epinephrine) is the initial treatment of choice, along with other measures as indicated. These may include placing the patient in a comfortable position, providing airway management, giving high flow oxygen, and rapidly administering a large volume of intravenous fluid. They also advise subsequent referral to an allergy specialist for risk assessment and institution of long term measures to reduce risk.

    No new drugs are available for the acute treatment of anaphylaxis. Currently used agents such as adrenaline, glucocorticoids, H1 antihistamines, and H2 antihistamines were introduced before the era of randomised controlled trials and evidence based medicine. Systematic reviews of these drugs are being conducted to document the existing evidence base.2 3 4 This consists of clinical experience and expert opinion, …

    Sign in

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe